Bioequivalence Studies of Dasatinib 100 Mg

Clinical trial NCT05944783 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05944783
Sponsor: Centro de Atencion e Investigacion Medica
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Myeloma Multiple

Start date: 2025-09-01
Primary completion: 2025-12-20
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.